I am an IT Manager with experience in the following industries: Pharma, Government, Banking and TelCo. I have a strong propensity for technological innovation, and its use inside companies to proactively contribute to processes improvement along the entire value chain.

Something about me from the professional point of view.
- Passionate of technology - My first pc, TI99/4A, when I was 11
- A strong advocate of adopting detailed work plans as enabler to get any goal
- Equipped with practical sense
- Being able to listen and valorize my team contribution

My history.
I graduated in Mathematics at the University of Rome, Tor Vergata. After a collaboration with the university, I worked in Mediamed Interactive, developing digital training solutions for the sales force of Pharma industry. After this experience, I joined Accenture and Avanade where I was involved in big projects/programs for the largest national and multinational companies.

After the consulting experience, I moved to Biomedica Foscama Group where, for more than five years, I was the head of IT department. Then, I moved to Alfasigma to lead IT activities for the Manufacturing area. Currently I’m in charge of IT development for the Manufacturing area covering all Alfasigma plants, with a particular focus on Industry 4.0. I’m also the CTO for the Pescara plant.

Ambitious and accomplished engineering leader with over 25 years of experience in driving operational excellence and strategic initiatives within matrix and multicultural environments in the pharmaceutical industry. Proven expertise in leading global teams, optimizing asset, and delivering projects.

Certified in Advanced Asset Management, with a focus on Continuous Improvement, Engineering, Performance, Digitalization and Compliance. Adept at fostering innovation, enhancing productivity, and creating significant business value through strategic execution and delivery.

The Pop in Your Job: In my role at GSK, I deliver innovative smart engineering solutions across various sites, focusing on enhancing asset uptime, equipment reliability, maintenance effectiveness, manufacturing capacity, and overall productivity. What drives me is the opportunity to collaborate with diverse teams, making their daily tasks easier and more efficient. I am passionate about the impact of new technologies on improving people's work experiences. The connection with sites worldwide allows me to embrace different cultures and address unique needs. Working for GSK, a company dedicated to bettering and improving human health, aligns with my values and commitment to contributing to a healthier world.

With over 15 years of specialized experience in pharmaceutical and biotech engineering, Oliver Kaerst is a distinguished leader in the field. As Head of Global Healthcare Operations (GHO) Engineering, he oversees engineering and capital expenditure initiatives across 20 manufacturing sites worldwide, driving excellence in pharmaceutical manufacturing and packaging.

Oliver has a proven track record in leading global pharma engineering and packaging reliability programs, including the successful integration of IoT and Industry 4.0 technologies. He also contributes as a key advisor on the Pharma Maintenance USA advisory board, where he offers expert guidance and highlights emerging trends in global maintenance practices.

His extensive background in strategic project management, regulatory compliance, and operational improvement underscores his leadership and deep expertise in optimizing complex global operations.

Pharmaceutical engineering leader with over 25 years of manufacturing experience spanning engineering disciplines including maintenance/reliability, capital projects, plant/process engineering, facilities management, and qualification/validation. Adept at engaging stakeholders, charting strategy, building networks, and developing effective organizations. Models behaviors that promote safety, compliance, continuous improvement, and accountability. Experienced with direct in-plant leadership as well as indirect influence across international organizations.

Our mission is to improve people's health and quality of life by offering caregivers and healthcare professionals therapeutic solutions according to the highest standards of quality and safety, in the name of innovation. Alfasigma is one of the leading Italian pharmaceutical companies, operating in over 100 countries worldwide with approximately 4,000 employees dedicated to research, development, production, and distribution. With more than 70 years of history, the Company has a longstanding track record in developing innovative therapeutic indications to meet the new needs of patients while renewing and consolidating its existing products. Alfasigma has a strong focus in gastroenterology and worldwide has products also in vascular, metabolic areas and in nutraceuticals and medical foods. As part of its strategy to expand its specialty care portfolio, Alfasigma strengthened its international presence with targeted acquisitions in US and Europe in 2023. Alfasigma’s historical headquarters are located in Bologna, with another office in Milan. It has production sites in Italy, in Pomezia (RM), Alanno (PE), Sermoneta (LT) and Trezzano Rosa (MI), and abroad in Tortosa, Spain and in Shreveport (Louisiana) in the United States. Its R&D laboratories are in Pomezia and in the Parco Scientifico Tecnologico Kilometro Rosso in Bergamo.

GSK is a global biopharma company with a mission to unite science, technology, and talent to get ahead of disease together. Our goal is to positively impact the health of 2.5 billion people by the end of the decade, fostering a thriving environment for our team. As a focused biopharma company, we specialize in preventing and treating diseases through specialty medicines, vaccines, and general medicines. Our research concentrates on the science of the immune system and advanced technologies, with significant investments in respiratory, immunology and inflammation, oncology, HIV, and infectious diseases. Our Ahead Together strategy emphasizes early intervention to prevent and change the course of diseases, supporting people and healthcare systems. We aim to discover new, better medicines and vaccines while also preventing illnesses and mitigating their long-term impacts. Our robust portfolio and pipeline continue to grow, with key milestones achieved across our core therapeutic areas in 2023. Strategic partnerships, such as those with the University of Oxford on neurodegenerative diseases, Kings College London on cancer treatment, and 23andMe on genetics and genomics, are vital to our discovery efforts. Our culture at GSK is driven by a commitment to being ambitious for patients, accountable for impact, and doing the right thing, ensuring that GSK remains an exciting and inspiring place to work. Our Code outlines the commitments we uphold to achieve our goals and bring our culture to life, making GSK a place where people can thrive.

Our passion for science and technology is what drives our around 63,000 employees across 65 countries to find solutions to some of today’s toughest challenges and create more sustainable ways to live. We are here for people at every step, helping create, improve and prolong life. We deliver personalized treatments for serious diseases and enable people to achieve their dream of becoming parents. We empower the scientific community. Our tools, services, and digital platform make research simpler, more exact, and help to deliver breakthroughs more quickly. We provide progressive treatment solutions that help improve access to health thanks to the accuracy of our tests and the reliability of our medicine. As a company, we are at the forefront of digital living. Our science sits inside technologies that change the way we access, store, process, and display information. Our innovative technology drives human progress and opens new possibilities to transform life on Earth as we know it. Thanks to the constant curiosity of our employees, we are making discoveries that can change the landscape of entire industries. For more than 350 years, we’ve been pushing the boundaries of what’s possible, and we’ll continue to do so in the years to come.

We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.